Skip to main content

Call for papers - Biotechnology in neurology and neuroscience

Guest Editors

Dilawar Hassan, PhD, Monterrey Institute of Technology and Higher Education, Mexico
Małgorzata Kujawska, PhD, DSc, Poznan University of Medical Sciences, Poland

Submission Status: Open   |   Submission Deadline: 24 July 2025

BMC Neurology is calling for submissions to a Collection focused on the intersection of biotechnology and neurology. We welcome submissions that explore innovative approaches to diagnosing and treating nervous system disorders, including molecular diagnostics, nanobiotechnology, and personalized neurology. This Collection aims to foster collaboration and inspire new solutions for improving patient outcomes in neurology and neuroscience.


New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 9: Industry, Innovation & Infrastructure.

Meet the Guest Editors

Back to top

Dilawar Hassan, PhD, Monterrey Institute of Technology and Higher Education, Mexico

Dilawar Hassan is currently affiliated with Tecnologico de Monterrey and has background in the field of Nanomedicines. For the past 10 years, Hassan has been working on the synthesis of nanomaterials using green chemical methods. Hassan has published his research is high impact factor journals related to biomedical applications of nanomaterials specifically the use of nanomaterials for their potential to treat neurodegenerative diseases, ani-cancer applications, and cyto-toxicity potential. His research interests include the development of drug loaded polymeric nanoparticles for safer drug delivery.
 

Malgorzata Kujawska, PhD, DSc, Poznan University of Medical Sciences, Poland

Malgorzata Kujawska, PhD, DSc, is a Professor at Poznan University of Medical Sciences, Poznan, Poland. She graduated with an MSc and PhD with a postdoctoral degree (habilitation) in pharmaceutical sciences. Her research focuses on therapeutic and neuroprotective approaches against neurodegeneration in synucleinopathies models. Prof Kujawska integrates nanotechnology and neuroscience in her research. She is an enthusiast of nanoneuroscience-based innovations in synucleinopathy management. Gut neuromicrobiology, which encompasses understanding the interplay between the gut microbiota, its neurometabolic interactome, and Parkinson’s disease, is her second research hotspot. Prof Kujawska is a recipient of the 2020 Matsumae International Foundation Research Fellowship Program. She completed workshops on entrepreneurship and design thinking at Stanford University within the government program “Top 500 Innovators”. She participated in an internship at NASA Ames Research Center at Synthetic Biology Innovation Lab. Prof Kujawska is a Chairwoman of the Poznan Branch of the Polish Society of Toxicology and a member of other scientific societies, including FENS and RCS. She also serves as an expert for Polish agencies financing R&D activities and for the European Commission.


 

About the Collection

BMC Neurology is calling for submissions to a Collection focused on the intersection of biotechnology and neurology. We welcome submissions that explore innovative approaches to diagnosing and treating nervous system disorders, including molecular diagnostics, nanobiotechnology, and personalized neurology. This Collection aims to foster collaboration and inspire new solutions for improving patient outcomes in neurology and neuroscience.

Neurobiotechnology is a rapidly evolving field that holds immense potential for advancing our understanding and treatment of nervous system disorders. Recent innovations, including molecular diagnostics and advancements in nanobiotechnology, are paving the way for more precise and effective interventions. These advancements are not only enhancing our ability to diagnose conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, but are also facilitating the development of targeted therapies that can improve patient outcomes. Furthermore, to understand the limitations of these therapeutics and explaining how to tackle the issues related with them. As we delve deeper into the complexities of the nervous system, including the gut-brain axis, the integration of biotechnological approaches is becoming increasingly vital.

The prevalence of neurological disorders is on the rise, necessitating innovative solutions to improve diagnosis and treatment. Significant strides have been made in personalized neurology, where therapies are tailored to individual profiles, and in therapeutic drug delivery systems that enhance drug efficacy while minimizing side effects. These advances underscore the importance of interdisciplinary research that combines insights from molecular biology, pharmacology, microbiology, and neuroscience to address the challenges posed by nervous system disorders.

Future advances could include the creation of more sophisticated neuroprosthetics, enhanced gene therapies for genetic neurological disorders, using a “digital twin” approach, and the use of artificial intelligence to predict disease progression and treatment responses. Such innovations have the potential to transform patient care and improve the quality of life for individuals affected by neurological conditions.

Topics of interest to this Collection include, but are not limited to:

  • Molecular diagnostics in neurology
  • Nanobiotechnology applications in nervous system disorders
  • Personalized approaches in neuropharmacology
  • Therapeutic drug delivery systems for neurological diseases
  • Limitations of Nanomedicines and nanocarriers
  • How nanomedicines interact with cells


Image credit: © science photo / stock.adobe.com

  1. Parkinson’s disease (PD), a prevalent neurodegenerative disorder in the aging population, poses significant challenges in unraveling its pathogenesis and progression. A key area of investigation is the disrupt...

    Authors: Yao Wang, Dongchuan Wu, Man Zheng and Tiantian Yang
    Citation: BMC Neurology 2025 25:161
    Content type: Research Published on:

  5. Autoimmune encephalitis associated with anti-GluK2 antibodies is a recently identified condition, typically characterized by cerebellar ataxia. This case report presents a unique clinical manifestation involvi...

    Authors: Zhengping Cheng, Yang Song, Shuqi Zhao, Xiaowen Sui, Lili Xie, Hongling Zhao, Xin Pan, Li Cui, Xinran Huang and Shubei Ma
    Citation: BMC Neurology 2025 25:27
    Content type: Case Report Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Biotechnology in neurology and neuroscience" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.